Bigfoot Biomedical, founded in Milpitas, California, is a medical technology startup focused on revolutionizing diabetes care. The company's core mission is to simplify and improve the lives of people with Type 1 diabetes through innovative technology. Their flagship product, the Bigfoot Unity Diabetes Management System, integrates continuous glucose monitoring (iCGM) data with healthcare professional recommendations to provide real-time insulin dosage guidance. Bigfoot Biomedical primarily serves the U.S. healthcare sector and patients managing Type 1 diabetes.

Notable figures associated with Bigfoot Biomedical include its founding team, who have personal connections to diabetes, driving their passion for impactful solutions. The company has garnered significant attention and investment from prominent venture capital firms in the MedTech space. Key achievements include the successful development and deployment of their automated insulin delivery system, which has been praised for its user-centric design and effectiveness. Bigfoot Biomedical's innovations have made a substantial impact on diabetes management, offering patients greater control and ease in managing their condition.